10-K: AdaptHealth Corp. Reports Mixed Results in 2024, Cites Inflation and Reimbursement Pressures

AdaptHealth Corp.'s 2024 10-K filing reveals a complex financial landscape, marked by revenue growth tempered by rising costs, regulatory challenges, and ongoing efforts to bolster internal controls.

Summary

• AdaptHealth Corp. reported a net revenue increase of 1.9% to $3.26 billion for the year ended December 31, 2024, driven by non-acquired growth and acquisitions.
• The Sleep Health segment saw a 4.5% revenue increase, while Respiratory Health grew by 6.0%, but the Diabetes Health segment experienced a 6.9% decline.
• The company recorded a goodwill impairment charge of $13.1 million related to the disposition of certain immaterial custom rehab technology assets.
• AdaptHealth is addressing a material weakness in internal control over financial reporting related to inventory valuation.
• The company is facing challenges related to inflation, supply chain disruptions, and reimbursement pressures from private payors.
• AdaptHealth is cooperating with civil investigative demands from the U.S. Attorneys Office related to billing practices.
• The company's strategic growth plan includes accretive acquisitions and leveraging its technology platform.
• AdaptHealth is subject to extensive government regulations, including healthcare fraud and abuse laws.
• The company is managing risks associated with cybersecurity, data protection, and climate change.
• AdaptHealth is implementing measures to remediate material weaknesses in its internal control over financial reporting.

Sentiment

Score: 5

Explanation: The document presents a mixed picture, with some positive revenue growth offset by challenges like declining performance in the Diabetes Health segment, a goodwill impairment, and ongoing regulatory scrutiny. The sentiment is neutral, reflecting the need for AdaptHealth to address its challenges while capitalizing on its strengths.

Positives

• Net revenue increased by 1.9% to $3.26 billion.
• Sleep Health and Respiratory Health segments experienced revenue growth.
• The company is actively working to remediate a material weakness in internal control over financial reporting related to inventory valuation.
• AdaptHealth is focused on growing through acquisitions and leveraging its technology platform.

Negatives

• The Diabetes Health segment experienced a revenue decline of 6.9%.
• A goodwill impairment charge of $13.1 million was recorded.
• AdaptHealth is facing challenges related to inflation, supply chain disruptions, and reimbursement pressures from private payors.
• The company is cooperating with civil investigative demands from the U.S. Attorneys Office related to billing practices.
• AdaptHealth is actively working to remediate a material weakness in internal control over financial reporting related to inventory valuation.

Risks

• Reliance on relatively few suppliers for patient service equipment and supplies.
• Supply chain disruptions and economy-wide labor shortages in the U.S.
• The impact of inflation and rising interest rates.
• Cyber-attacks, security breaches, or improper disclosure of protected health information.
• Continuing efforts by private third-party payors to control their costs.
• Changes in governmental or private payor supply replenishment schedules.
• Reliance for a significant portion of revenue on the provision of sleep therapy equipment and supplies.
• Consolidation among health insurers and other industry participants.
• Failure to maintain controls and processes over billing and collections.
• Ability to effectively implement controls and procedures required by the Sarbanes-Oxley Act.
• Ability to maintain or develop relationships with patient referral sources.
• Competition from numerous other sleep therapy equipment, home respiratory, mobility equipment, and diabetes medical devices and supplies providers.
• Risks related to government regulation, including federal and state changes to reimbursement and other Medicaid and Medicare policies.
• Changes in medical equipment technology and development of new treatments.
• The use or anticipated use of artificial intelligence (AI) technologies.
• The risk of rupture or other accidents due to the transport of compressed and liquid oxygen.
• Outsourcing of a portion of internal business functions to third-party providers.
• Ability to attract and retain key members of senior management and other key personnel.
• Ability to execute strategic growth plan, which involves the acquisition of other companies.
• The impact of political and economic conditions.
• Changes in the authorizations or documentation necessary for products we provide.
• Significant reimbursement reductions and/or exclusion from markets or product lines.
• Our ability to maintain required licenses and accreditation.
• The impact of global climate change and legal, regulatory or market responses to such change.
• Our ability to generate sufficient cash flow or obtain additional capital to fund our operating subsidiaries and finance our growth.
• Significant expenses and administrative burdens as a result of being a public company.

Future Outlook

The company believes that its expected operating cash flows, together with its existing cash and amounts available under its existing credit agreement, will continue to be sufficient to fund its operations and growth strategies for at least the next twelve months. AdaptHealth may seek additional equity or debt financing in connection with the growth of its business, primarily for acquisitions.

Management Comments

• AdaptHealth leverages applicable guidelines from standards such as the National Institute of Standards and Technology (NIST) Special Publication 800.
• AdaptHealth has internal programs to identify and remediate vulnerabilities in its infrastructure and applications, and it deploys market leading defense tools to protect and secure its network and data.
• AdaptHealths security measures aim to prevent cyber threats and vulnerabilities.
• AdaptHealth believes that these processes are essential to support its compliance, internal controls and efficiency initiatives.

Industry Context

The HME market is fragmented and highly competitive, with consolidation being a continuing trend. AdaptHealth competes with other large national providers, regional providers, and product-specific providers. The Medicare Durable Medical Equipment, Prosthetics, Orthotics, & Supplies (DMEPOS) Competitive Bidding Program also emphasizes the importance of relationships with both the payors and referral sources.

Comparison to Industry Standards

• AdaptHealth's largest national home respiratory/home medical equipment provider competitors include Owens & Minor Inc., Lincare Holdings Inc., Rotech Healthcare, Inc., Cardinal Health, Inc. and Quipt Home Medical Corp.
• The rest of the homecare market in the United States consists of regional providers and product-specific providers, as well as numerous local organizations.
• Hospitals and health systems are routinely looking to provide coverage and better control of post-acute healthcare services, including homecare services of the types AdaptHealth provides.

Management Changes

Legal Proceedings

• The company is cooperating with civil investigative demands from the U.S. Attorneys Office related to billing practices.
• The company is involved in a shareholder derivative complaint related to the allegations in the Allegheny County Complaint.

Related Party Transactions

• The company and one of its former executive officers (who was a member of the board of directors through December 31, 2024) own an equity interest in a vendor of the company that provides automated order intake software.
• A director of the company serves on the board of directors of a third-party payor that does business with the company in the normal course of providing services to patients.
• A director of the company is an employee of a beneficial owner of more than 5% of the company's Common Stock as of December 31, 2024. This beneficial owner is also a minority shareholder of a vendor that provides medical equipment and supplies to the company in the normal course of business.
• A former regional manager of the company is a shareholder of a business which provides contract labor to the company.

Stakeholder Impact

• Shareholders may be impacted by the company's financial performance, regulatory challenges, and legal proceedings.
• Employees may be impacted by changes in management, cost savings initiatives, and the company's commitment to diversity and inclusion.
• Customers may be impacted by changes in service quality, product offerings, and reimbursement policies.
• Suppliers may be impacted by changes in purchasing power and vendor negotiations.
• Creditors may be impacted by the company's ability to generate sufficient cash flow to cover required payments and comply with financial covenants.

Next Steps

• Continue to implement measures to remediate the material weakness in internal control over financial reporting.
• Monitor developments regarding the DMEPOS Competitive Bidding Program.
• Adapt to future legislative and regulatory changes.
• Monitor and respond to the impacts of global climate change.
• Continue to monitor the worsening macroeconomic conditions, such as the war in Ukraine, the conflict in the Middle East and global geopolitical tension.

Key Dates